2023 Conference Archive: Speakers
Irene Nunes
VP, Head of Regulatory Affairs, Flatiron Health, Chair of the ExecutiveBoard GetReal Institute
Catherine Cohet
Pharmacoepidemiology Senior Specialist,Data Analytics and MethodsTask Force,European MedicinesAgency(EMA)
Wija Oortwijn
PhD, Senior researcher, Radboud university medical center/HTAi President
Rick Grobbee
Professor of Clinical Epidemiology,University Medical Center Utrecht(UMCU)
Bettina Ryll
Founder, Melanoma Patient Network Europe (MPNE)
Virginia Acha
Global Regulatory Policy, MSD
Andrew Roddam
Chief Executive Officer,Our Future Health UK
Gracy Crane
Executive Director Integrated Solutions, Evidera
Nigel Hughes
Scientific Director, Observational Health Data Analytics/Epidemiology,
Johnson & Johnson &EHDEN Project Lead
Mira Zuidgeest
Epidemiologistand Associate Professor,University Medical CenterUtrecht(UMCU)
Shahid Hanif
Managing Director, GetReal Institute
Darren Toh
Principal Investigator | Sentinel Operations Center, Harvard Medical School & Harvard Pilgrim Health Care Institute
Peter Mol
Principal Clinical Assessor CBG-MEB (Dutch Medicines Evaluation Board),
Professor of drug regulatory science, University Medical Center Groningen; Member SAWP
Sebastian Garcia Marti
Coordinator of Health Technology Assessment (HTA) and Economic Evaluation, IECS(Argentina)
Churn-Shiouh Gau
Adjunct Professor, School of Pharmacy, National Taiwan University
Donna Rivera
Associate Director of Pharmacoepidemiology | RWD & RWE at FDAOncology Center of Excellence
Inka Heikkinen
Director, Global Regulatory Policy, EMEA,MSD
Wim G. Goettsch
Professor HTA of Pharmaceuticals, WHO Collaborating CentreforPharmaceutical Policy and Regulation; Division of Pharmacoepidemiology and ClinicalPharmacology, Utrecht University
Mark McClellan
MD, PhD, Robert J. Margolis Professor of Business, Medicine, and Policy, and founding Director of the Duke-Margolis Center for Health Policy at DukeUniversity